Oragenics (OGEN) Institutional Ownership $1.32 -0.08 (-5.40%) As of 12:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for Oragenics (NYSEAMERICAN:OGEN)CurrentInstitutional OwnershipPercentage18.71%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$328.36KNumber ofInstitutional Sellers(last 12 months)0 Get OGEN Insider Trade Alerts Want to know when executives and insiders are buying or selling Oragenics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data OGEN Institutional Buying and Selling by Quarter Oragenics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025Bank of America Corp DE15,546$59K0.0%+7,374.0%1.889% 8/13/2025Clear Street LLC70,619$270K0.0%N/A8.581% 5/20/2024Virtu Financial LLC22,675$33K0.0%N/A0.506% 1/11/2023Sara Bay Financial1,271,281$134K0.1%-36.7%1.084% 2/14/2022GSA Capital Partners LLP410,944$183K0.0%+150.6%0.353% 1/14/2022Sara Bay Financial2,008,117$896K0.3%+99.2%1.725% 11/15/2021GSA Capital Partners LLP163,954$104K0.0%N/A0.141% 11/12/2021Renaissance Technologies LLC894,205$568K0.0%+254.1%0.768% 9/17/2021Virtu Financial LLC65,456$46K0.0%+212.9%0.056% 8/17/2021Bridgeway Capital Management LLC140,000$99K0.0%-68.8%0.121% 8/16/2021State Street Corp454,325$321K0.0%N/A0.393% 8/13/2021Renaissance Technologies LLC252,564$178K0.0%N/A0.218% 8/13/2021Geode Capital Management LLC731,304$515K0.0%+36.6%0.632% 8/13/2021Vanguard Group Inc.5,031,450$3.55M0.0%+11.3%4.351% (Data available from 1/1/2016 forward) OGEN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OGEN shares? During the previous two years, the following institutional investors and hedge funds held shares of Oragenics shares: Clear Street LLC ($270K), and Bank of America Corp DE ($59K), Virtu Financial LLC ($33K).Learn more on Oragenics' institutional investors. What percentage of Oragenics' stock is owned by institutional investors? 18.71% of Oragenics' stock is owned by institutional investors. Learn more on OGEN's institutional investor holdings. Which institutional investors have been buying Oragenics' stock? The following institutional investors have purchased Oragenics' stock in the last 24 months: Clear Street LLC ($70.62K), Virtu Financial LLC ($22.68K), and Bank of America Corp DE ($15.34K). How much institutional buying is happening at Oragenics? Institutional investors have bought a total of 85,957 shares in the last 24 months. This purchase volume represents approximately $328.36K in transactions. Related Companies Citius Pharmaceuticals Institutional Ownership NanoViricides Institutional Ownership Cingulate Institutional Ownership Lixte Biotechnology Institutional Ownership FibroBiologics Institutional Ownership Clearside Biomedical Institutional Ownership Leap Therapeutics Institutional Ownership Rallybio Institutional Ownership Lisata Therapeutics Institutional Ownership ProPhase Labs Institutional Ownership This page (NYSEAMERICAN:OGEN) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. ...American Alternative | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oragenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oragenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
